Discover with Delta4

Delta4’s CEO, Kurt Herpel, and CSO, Klaus Kratochwill, were recently featured on the PharmaVentures podcast, where they discussed how Delta4 ...

The use of multiple active ingredients in medicine is a time-honored practice, with roots stretching back to Traditional Chinese Medicine ...

At Delta4, we leverage multi-omics data to identify novel drug repurposing opportunities by uncovering molecular similarities between diseases and existing ...

Developing new treatments for complex diseases presents a myriad of challenges, ranging from understanding the disease’s mechanisms to ensuring the ...

As we step into 2024, the pharmaceutical industry stands at the cusp of remarkable advancements and significant transformations. This year ...

In the realm of healthcare, the journey from a promising drug idea to an effective therapy is not a straightforward ...

In the intricate world of healthcare, the journey of a drug from a basic idea to a therapy that can ...

The world of pharmaceuticals is complex and layered. At the heart of this realm is the drug discovery pipeline, a ...